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Abstract Chandipura virus, a member of the rhabdoviridae family and vesiculovirus
genera, has recently emerged as human pathogen that is associated with a number of
outbreaks in different parts of India. Although, the virus closely resembles with the
prototype vesiculovirus, Vesicular Stomatitis Virus, it could be readily distinguished by
its ability to infect humans. Studies on Chandipura virus while shed light into distinct
stages of viral infection; it may also allow us to identify potential drug targets for
antiviral therapy. In this review, we have summarized our current understanding of
Chandipura virus life cycle at the molecular detail with particular interest in viral RNA
metabolisms, namely transcription, replication and packaging of viral RNA into
nucleocapsid structure. Contemporary research on otherwise extensively studied family
member Vesicular Stomatitis Virus has also been addressed to present a more
comprehensive picture of vesiculovirus life cycle. Finally, we reveal examples of protein
economy in Chandipura virus life-cycle whereby each viral protein has evolved
complexity to perform multiple tasks.
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Introduction
RNA viruses posses highest mutation rate among all known self-replicating beings
(Holland et al. 1982) that offers considerable ‘‘long-term’’ evolutionary advantages
over its host, organisms with DNA genome repertoire (Elena and Sanjuan 2005). Not
surprisingly, out of ~50 new viruses that have been recognized as emergent in the past
two decades, most of them are deadly RNA viruses. An outbreak of severe febrile
encephalitis in Malaysia with reports of human deaths in 1998–99 was associated with
Nipah virus (Chua et al. 2000). Coronavirus associated with Severe Acute Respiratory
Syndrome (SARS) posed a threat of epidemic in 2003 with rapid spread across the
eastern Asia (Marra 2003). In another recent outbreak, a deadly strain of avian flu
virus H5N1 spread across the parts of three different continents from 2004 to 2006
through poultry trading as well as migratory birds (Ducatez et al. 2006; Chen et al.
2005). These occurrences indicated increased susceptibility of the modern day human
civilization intimately connected within a global village towards potential viral
pandemics.
Chandipura virus (CHPV) was first isolated in 1965 from a patient suffering from
febrile illness in a village called Chandipura in India and was shown to have cytopathic
effect on cells in the tissue culture (Bhatt and Rodrigues 1967). Later, in 1977 another
virus strain was isolated from hedgehog in Ibadan, Nigeria (Clewley et al. 1977).
Although, CHPV was known to cause mild symptoms upon human infection and was
also isolated from encephalopathy patient in 1980 (Rodrigues et al. 1983), only in 2003
first evidence for its association in human epidemics was obtained when CHPV was
identified from patient samples during an outbreak of acute encephalitis with high
fatality rate in India (Rao et al. 2004). Subsequently, another outbreak of encephalitis
associated with CHPV infection with more than 75% fatality rate was reported in the
eastern state of Gujarat in India in 2004 (Chadha et al. 2005). These occurrences
indicated possible emergence of Chandipura virus as a deadly human pathogen in
Indian Subcontinent.
CHPV was identified as probable causative agent associated with the epidemics
based on reliable tools such as serological examination, electron microscopy and other
molecular analyses. Although, high mutation rate among RNA viruses could results in
evolution of deadly strains, possibilities of CHPV being a passenger or concomitant
virus could not be completely ruled out from above mentioned case-studies (Potharaju
and Potharaju 2006). Therefore, further investigations are required to obtain evidences
that supports the principles forwarded by Koch’s postulates to unequivocally establish
CHPV as an emerging human pathogen (Nature Reviews Microbilogy editorial 2006;
Van Ranst 2004). Nonetheless, isolation of CHPV from sand flies earlier in 1967
(Dhanda et al. 1970) and also during the recent epidemic (Rao et al. 2004) lead to
suspect sand fly as a potential vector for this viral pathogen.
In this review, we aim to provide a general insight on Chandipura Virus life cycle and
discuss our current understanding on molecular events associated with the decoding of
its genetic information as well as replication of viral genome. Pathways for encapsi-
dation of progeny genome RNA into a nuclease resistant structure have also been
addressed to forward a refined model for nucleocapsid assembly. Understanding gained
from the parallel studies in closely related Vesicular Stomatitis Virus (VSV) was
discussed to reveal both generalized mechanisms and distinct modes associated with
Chandipura virus pathogenesis.
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Chandipura Virus: A General Overview
Chandipura virus has been assigned into vesiculovirus genus and rhabdoviridae family
within the virus order mononegaviridae. CHPV and other mononegavirales are
characterized by non-segmented, single stranded RNA genome of anti-message sense
(negative sense) (David M. Knipe 2001). Among them, rhabdoviruses received major
attention due to their wide host range starting from human and other vertebrates, fish,
arthopods, members of plant kingdom, and as causative agents for loss in livestocks,
agricultural products and in fisheries. Viruses belonging to this family owe its name
rhabdo, meaning rod-shaped in Greek, to the typical bullet shaped morphology and
include human pathogens such as CHPV (Fig. 1a) or rabies. Similarities between CHPV
and VSV in genetic makeup, polypeptide composition and life cycle lead to include
CHPV within vesiculovirus genus (Banerjee 1987a).
Virus Life-cycle
Vesiculovirus life cycle can be divided into discrete steps, namely, adsorption of virus
particle, penetration of virus into cell, uncoating and release of core RNP into the
cytosol from late endosomal vesicles, transcription of the genome by viral polymerase,
translation of viral mRNA, post-translational modifications of viral proteins, replication
of viral genome, assembly of progeny particles and finally budding of mature virion.
Entire vesiculovirus life cycle within infected cell is cytosolic (Banerjee 1987a). Genome
RNA enwrapped with Nuleocapsid protein N acts as a template for sequential
transcription starting from 3¢end of the genome to synthesize short leader RNA and five
monocistronic capped and poly adenylated viral mRNAs. Viral RNA dependent RNA
polymerase (RdRp) is composed of Large protein L, the catalytic subunit and
phosphorylated form of Phosphoprotein P that acts as a transcriptional activator.
Translation of viral mRNAs results in accumulation of viral polypeptides within
infected cells and set up stage for the onset of genome replication (Banerjee 1987a; Barr
et al. 2002). During replication, the same polymerase switches to replicative mode to
copy entire genomic template into an exact polycistronic complement that acts as
replication intermediate to produce many more copies of (–) ve sense genomes upon
further rounds of replication. Progeny (–) ve sense genomes are also subjected to
transcription, referred to as secondary transcription. Notably, virus specific genomic
analogues, and not mRNAs, always remain encapsidated by N, while, it is believed that
progressive encapsidation of nascent genome RNA during its synthesis is necessary for
replication and/or protecting replication product from cellular RNases (Banerjee 1987a;
a
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Fig. 1 (a) A schematic presentation of bullet shaped Chandipura virus with glycoprotein G protruding
out of the viral envelope. (b) A proposed view of Chandipura virus genome RNA encapsidated with
Nucleocapsid protein. Nucleocapsid protein binds to viral RNA to enclose it in a disc like structure. This
disc like structures stacks on each other to generate a helical assembly, as depicted, to form core
nucleocapsid. Phosphoprotein P and Large Protein L remain associated with N-RNA
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Barr et al. 2002). Below, we will discuss individual components of Chandipura virus and
their role in viral life cycle.
Chandipura Virus and its Genome Organization
CHPV is surrounded by lipoprotein envelope, which encloses a helical ribonucleopar-
ticle (RNP) with a non-segmented single strand RNA enwrapped by N. Components of
viral RdRp, L and P are also packaged within the mature virion and remained
associated with core nucleocapsid particle. Glycoprotein G protrudes externally from
the outer membrane while Matrix protein M lies in the inner bilayer of the membrane.
CHPV genome RNA comprises of a 49 nt leader gene (l), followed by five
transcriptional units coding for viral polypeptides separated by intragenic spacer regions
and a short non-transcribed 46 nt trailer sequence (t) arranged in the order 3¢ l-N-P-M-
G-L-t 5¢. Sequence for (+) leader RNA of CHPV was determined in 1983 (Giorgi et al.
1983), while N and P gene was sequenced in 1987 (Masters and Banerjee 1987).
Subsequently, sequences for M and G gene along with parts of L gene was determined
(Masters et al. 1989; Taylor et al. 1999). Its only recently, complete sequence for L gene
of CHPV was obtained to construct a full-length genome map of this virus (Marriott
2005). Interestingly, comparative sequence analysis proposed CHPV to be evolutionary
equidistant from the new world vesiculoviruses VSV Indiana (VSVind) and VSV New
Jersey (VSVnj) and rather closely related to the Asian vesiculovirus Isfahan (Marriott
2005).
Glycoprotein G
Glycoprotein, G is the sole spike protein of CHPV that enables virus absorption,
assembly and budding. It also elicits antibody response thus acting as a major antigenic
determinant (Neumann et al. 2002). Studies on CHPV-G protein expressed from a
cloned DNA revealed presence of a N-terminal cleavable signal peptide, two N-liked
glycosylation sites at the N-terminal ectodomain, a membrane anchor domain and a
cytosolic domain at the C-terminus (Masters et al. 1989). Previous studies revealed that
VSV glycoprotein can exists as trimer (Zagouras and Rose 1993). It may reversibly
adopt three distinct conformational states; the native state present on the virus surface
and stable above pH 7 (Clague et al. 1990), the activated state that fuses with target
membrane (Durrer et al. 1995) and a fusion inactive postfusion state that is stable under
low pH condition (Yao et al. 2003). It was proposed that low pH induced conforma-
tional change in the G protein within endosome subsequent to viral entry enables
membrane fusion to release core particle in two sequential steps into the host cytoplasm
(Le Blanc et al. 2005).
Recently, crystal structure of the VSV-G protein ectodomain has been solved in its
postfusion state to reveal classic hairpin conformations, large numbers of protonated
residues stabilizing low pH state and also a novel fold combining features of class I and
class II fusogenic peptides (Roche et al. 2006). In light of the prediction that other
rhabdoviral glycoproteins display similar folds (Roche et al. 2006), homology modeling
of G protein form Chandipura virus Nagpur strain and sequences derived from the
epidemic associated strains may allow us to gain insight into viral pathogenesis. It is
interesting to note that almost all of the amino acid substitutions in G protein sequences
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of epidemic associated virus strains were observed within the ectodomain, a viral tool
for host invasion (Arankalle et al. 2005).
Matrix protein M
The matrix protein, M lies in the inner surface of the virion to tether core nucleocapsid
to the membrane. Highly basic N-terminal domain, with eight lysine residues, enables
membrane binding (Ogden et al. 1986) and is separated from the rest of the polypeptide
by a triple proline sequence (Rose and Gallione 1981). Crystal structure of VSV-M
protein revealed contributions from additional domain in membrane association and
presence of a flexible link conserved among mononegavirales that provide proper
alignment to the membrane binding domain (Gaudier et al. 2002). M protein also
interacts with and recruits mature nucleocapsid particles to the membrane during viral
assembly and budding. Moreover, M protein was shown to inhibit viral transcription
presumably by inducing a higher order condensed conformation of the RNP (De et al.
1982).
Research in the last few years, however, recognized Matrix protein as a deadly
weapon in rhabdoviral arsenal that perhaps alone may account for the observed
cytotoxicity in virus infected cells (Licata and Harty 2003). VSV-M was shown to shut
off host transcription by RNA polymerase I and II (Ahmed and Lyles 1998). It was
capable of inhibiting nuclear export of host mRNA and snRNA (Petersen et al. 2001)
by targeting nucleoporin Nup98 present at the nuclear rim (von Kobbe et al. 2000). M
protein mediated inhibition of host gene expression constitute for an example of viral
mechanism to suppress cellular interferon response (Enninga et al. 2002). Marriot and
co-workers cloned Chandipura virus Matrix protein gene in 1999 to subsequently show
its detrimental effect on transcription from cytomegalovirus immediate early promoter
in vivo (Taylor et al. 1999). Despite only 28% amino acid sequence identity with VSV,
CHPV-M also preserved the ability to inhibit host nucleo-cytoplasmic transport
(Petersen et al. 2001). Recently, another full-length clone of CHPV-M was indepen-
dently constructed by D.J. Chattopadhyay and his co-workers and functional charac-
terizations are underway. Additional works on CHPV-M protein are required to
completely understand multiple levels of intervention within the cellular signaling
network by human rhabdoviruses.
Ribonucleoprotein (RNP) Particle
Ribonucleoprotein particle is composed of core nucleocapsid and associated viral RdRp
subunits. RNP itself is infectious as it contains all the enzymatic activity necessary for
RNA synthesis and could produce progeny virus particles when artificially introduced
within cell (Thornton et al. 1983).
Nucleocapsid Assembly and Maturation
Core nucleocapsid of Chandipura virus is composed of 11,119 nt long genome RNA
(Marriott 2005) tightly enwrapped by ~1,200 molecules of N with requirement of one N
molecule for 9 nt (Thomas et al. 1985). While, encapsidated RNA enjoys protection
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from cellular RNase, viral RdRp does not recognize genome RNA as template unless
presented in an enwrapped conformation (Banerjee 1987a, b; Thomas et al. 1985).
Structure of viral RNA inside intact nucleocapsid was examined by Iseni et al. using a
combination of chemical probes (Iseni et al. 2000) to reveal that the ribonucleotide
bases are in general available for chemical modifications in VSV nucleocapsid, while the
phosphate groups present in RNA backbone are not. They also observed that bases
present in certain region of the enacpsidated genome RNA are less reactive
independent of the associated P or L protein. These observations, along with previous
studies (Keene et al. 1981), suggested that N primarily interacts with phosphate
backbone to enwrap genome RNA and present sequestered RNA in a specialized
conformation.
Ming Luo and his colleagues have recently reported that bacterial co-expression of
N and P protein resulted in a complex with 10 molecules of N, 5 molecules of P and a
~90 nt long RNA of bacterial origin. A low salt treatment readily dissociated P to
obtain a decamer N complex associated with RNA. Electron micrograph of decamer
N revealed a disk-like appearance (Green et al. 2000) with disk size simlar to one turn
of helix in viral nucleocapsid particle (Thomas et al. 1985). Single particle electron
microscopy revealed that RNA molecule is closely associated with inner surface near
the top end of such highly symmetrical disc (Chen et al. 2004). Accordingly, it was
proposed that this disc-like particle assembles into a helical structure by stacking on
each other to form viral nucleocapsid (Fig. 1b). Finally, crystal structure of these N
discs associated with RNA was solved (Green et al. 2006) to reveal that the RNA is
tightly bound in a cavity at the interface between two lobes of the N protomer, with
nine nucleotides of RNA associated with each N polypeptide. RNA binding cavity
within N molecule was considerably positively charged. Residues that are involved in
direct association with phosphates of RNA are spread across the N protein. Out of six
residues that contact phosphates, four are conserved among different rhabdoviruses,
implying a similar mode of RNA binding. Tyr 21, which apparently stacks against
nucleotide 1 of the bound RNA, is substituted in CHPV-N by phenylalanine, another
aromatic amino acid. An extensive network of interactions between neighboring N
molecules was also revealed with each N monomer contact with three other N
monomers. A hinge region between two lobes of N protomer was proposed to provide
necessary flexibility such that RNP can adopt alternative conformations at different
stages of maturation.
Unlike Tobacco Mosaic Virus, vesiculovirus N protein is not completely dissociated
from viral RNA during RNA synthesis. How could viral polymerase possibly read
sequences during transcription while genome RNA is enwrapped by N? Based on
chemical probing experiments it was suggested that bases are available on the surface of
the nucleocapsid for polymerase recognition (Iseni et al. 2000). However, crystal
structure of the nucleocapsid-like particles revealed that out of 9 nt associated with each
N monomer, bases in position 5, 7 and 8 are completely shielded by N thus conceivably
prevented from forming RNA duplex during transcription (Green et al. 2006).
Therefore, it was postulated that viral RNA is temporarily dissociated from N protein
within the active polymerase complex during transcription, a possibility also suggested
by Banerjee (1987a, b). Reports of similar structure for rabies virus nucleoprotein-RNA
complex (Albertini et al. 2006) and identification of disc-like appearances for CHPV-N
(Majumdar et al. 2004) allowed us to built up a conceptual framework towards
understanding conserved pathways for rhabdoviral nucleocapsid assembly (discussed
later). Nonetheless, nucleocapsids are subjected to further state transitions, presumably
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involving M protein, from an undulating ribbon to tightly coiled helix before packaging
within mature virus (Thomas et al. 1985).
Chandipura Virus N protein and Encapsidation
Chandipura virus N gene was sequenced almost two decades ago to reveal ~50%
sequence homology to N protein of VSVind or VSVnj serotypes (Masters and Banerjee
1987). However, it is only recently a full-length clone of N, its recombinant expression,
biochemical and biophysical characterizations has been reported (Majumder et al.
2001). CHPV-N gene codes for a 422 amino acid polypeptide with no reports for any
significant post-translational modifications. Comparison of rhabdovirus and paramyxo-
virus N proteins revealed a region with significant identity at the center of the
polypeptide (Masters and Banerjee 1987) that has been implicated for N–N association
(Banerjee 1987a). Recent crystallographic data on VSV-N protein indicated that this
central region forms constituents of both N- and C-terminal lobe and thus probably
instrumental in maintaining overall architecture of the protein (Green and Luo 2006).
Viral RNA
Unrelated RNA
P Protein
N Protein
  / DOC
DOC
I
II
Fig. 2 A Schematic depiction of specific yet processive encapsidation of Chandipura virus genome RNA
by Nucleocapsid protein N. The picture describes self-assembly of N protein monomer into oligomer that
binds to leader RNA or unrelated RNA. Dissociating detergents such as deoxycholate disrupts those
oligomer into monomer units and also prevents further oligomerisation. Phosphoprotein P associates
with N to keep N protein in a monomer form. This monomer N is able to recognize specific sequence
present on leader chain in the nucleation step (I) and is recruited to the viral RNA with concomitant
release of P. Subsequently, additional N molecules associates with RNA bound N monomers in the
elongation phase (II). N polymerization mediates a conformational change, thus, generates broad
specificity within RNA binding interface of N protein and allows for progressive encapsidation to enclose
RNA into a helical conformation. This model posit important role of N polymerization on its RNA
binding specificity and encapsidation. A proposed stem-loop structural element within leader sequence
has also been depicted
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The major biological property of N is to bind with nascent leader RNA to initiate
encapsidation of replication product concurrent to synthesis (Blumberg et al. 1983,
Wertz 1983; Patton et al. 1984; Banerjee 1987a). However, aggregation prone nature
of N poses a major obstacle towards biochemical characterizations. Encapsidation
competent N synthesized in a cell-free system was not sufficient for extensive
structure-function analysis (Patton et al. 1983). Native viral protein obtained after
dissociating from RNA (Blumberg et al. 1984) or recombinant protein obtained by
over-expressing within eukaryotic cellular milieu (Sprague et al. 1983) forms aggre-
gates. Bacterially over-expressed protein, recovered by denaturation/ refolding,
required high salt to prevent precipitation, therefore, compromising the scope for
wide biochemical applications (Das and Banerjee 1993). However, its was observed
that Phosphoprotein P, through, its C-terminus interacts (Takacs et al. 1993) and
keeps N in a soluble form (Howard and Wertz 1989; Green et al. 2000; Gupta and
Banerjee 1997). Accordingly, N-P complexes of various molar ratios was observed
within infected cells (Masters and Banerjee 1988b; La Ferla and Peluso 1989). Gupta
et al. successfully co-expressed N and P protein from two independent transcriptional
units within bacteria to obtain soluble N–P complex (Gupta and Banerjee 1997). Their
expression condition resulted in formation of large set of aggregates, which was
prevented by co-expression of N and P from a single polycistronic unit that apparently
maintained precise molar ratio of N and P protein to enable nucleocapsid-like
particles formation (Green et al. 2000).
However, Basak et al. were able to express a soluble form of CHPV-N protein in
bacteria circumventing the need for co-expressed P (Majumder et al. 2001). Transmis-
sion electron microscopy of homogenously purified CHPV-N removed from detergent
revealed similar disc-like appearances (Majumdar et al. 2004) as obtained for VSV N–P
complex. Subsequent studies revealed a role for osmolytes in preventing further
aggregation of this oligomer N (Majumder et al. 2001). P was identified as a N specific
chaperone that prevented N aggregation in vitro and in vivo independent of its
phosphorylation status (Majumdar et al. 2004). One important difference between N
preparations described for CHPV and those reported by Green et al. was the absence of
detectable amount of bacterial RNA in CHPV-N (Majumdar et al. 2004; Bhattacharya
et al. 2006). Rather, purified CHPV-N was shown to interact with RNA of viral or non-
viral origin in vitro (Majumdar et al. 2004; Bhattacharya et al. 2006; Majumder et al.
2001), substantiating the conclusion that N preparation was not saturated for RNA
binding. Considering a high degree of sequence homology, these apparent contradic-
tions were striking and may arise from high salt purification protocol used to obtain
CHPV-N, which could potentially dissociate bound RNA (Bhattacharya et al. 2006;
Majumder et al. 2001). However, it seems possible that N rapidly polymerizes as soon as
it is synthesized thus were unable to enclose RNA into the disc like structures, when
expressed alone in bacteria (Bhattacharya et al. 2006; Majumdar et al. 2004). Whereas,
co-expressed P prevented such self-assembly and allows for defined polymerization of N
protein on RNA chain. Based on their study in VSV, Green et al. (2000) predicted a
transient yet indispensable role for P in appropriate assembly of N into a nucleocapsid-
like particles, whereas, absence of P would result in an aggregated N that is incapable of
RNA binding. Therefore, studies on CHPV suggest existence of additional possible
mechanisms for rhabdoviral N protein assembly in a P independent manner (Majumdar
et al. 2004).
Although, N protein displays broad sequence specificity that is consistent to the
observed mode of RNA binding in crystal structure, proper initiation of the
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encapsidation requires specific recognition of the sequence elements present at the
genome termini (Blumberg et al. 1981, 1983; Pattnaik et al. 1995). How does N maintain
a dual status, i.e. its ability to recognize specific sequence on nascent RNA (nucleation)
and still progressively encapsidate RNA of diverse sequences (elongation)? While,
VSV-N crystal structure provided insight into the molecular interactions present within
mature nucleocapsid, recent studies on CHPV-N described a dynamic model for N-
mediated nulcleocapsid assembly (Bhattacharya et al. 2006). In their experiment,
Bhattacharya et al. used a dissociating detergent deoxycholate to disrupt oligomeric disc
structure of bacterially expressed N protein to obtain monomer N. Furthermore, they
removed the detergent from N preparation in presence of Phosphoprotein to reveal that
P prevents re-assembly of N into oligomer and maintain it in a monomer form, in vitro.
Subsequently, they compared RNA binding specificities of monomer N and its
oligomeric counterpart. These course of studies strikingly revealed that monomer N
could recognize specific sequence present within the first 21 nucleotides of (+) leader
RNA whereas oligomer N shows a compromised RNA binding specificity. Finally, viral
minigenome length RNA sequestered N from its P bound monomer form to initiate
appropriate encapsidation into a nuclease resistant structures.
Based on this analysis and new insights gained from structural studies, we propose a
two-step model for encapsidation that requires monomer N as a building block (Fig. 2).
In the nucleation step, monomer N that poses an intrinsic RNA binding specificity
recognizes viral sequences on nascent leader RNA to initiate nucleocapsid assembly.
Subsequent N–N association during elongation phase results in subtle conformational
change to allow for compromised binding specificity so that newly polymerized N on
RNA molecule can bind to heterogenous sequences. While, a fast reversible interaction
between N and P protein ensures supply of additional N monomers, N–N as well as N-
RNA association, traps N from N–P complex within encapsidation complex during
elongation. In this proposal, P modulates oligomeric status of N protein to allow for
appropriate encapsidation of viral RNA.
This mechanistic model was able to provide explanation for many of the published
reports. Previous studies with VSV-defective interfering (DI) particle revealed that the
5¢terminal 36 nucleotides and 3¢terminal 51 nucleotides of the genome are sufficient for
replication, encapsidation and budding (Pattnaik et al. 1995). In vitro assembly assay
with synthetic nucleocapsid identified the first 19 nt from the 5¢end of the (+) sense RNA
as necessary component for encapsidation (Moyer et al. 1991). Moreover, a heterologous
sequence when fused downstream to the first 19 nt sequence from viral RNA, supported
encapsidation, thus confirming a compromised specificity in the ensuing encapsidation
process (Moyer et al. 1991). Also, a large network of N–N interactions was shown to
stabilize nucleocapsid assembly, therefore, consistent to the need for association between
N proteins in enduring encapsidation. N protein expressed in bacteria or in mammalian
cell in absence of P assembles into aggregate (Das and Banerjee 1993; Majumdar et al.
2004). This oligomeric N was shown to form RNase resistant complexes with leader RNA
(Blumberg et al. 1983), but was unable to encapsidate longer VSV RNA in vitro (Moyer
et al. 1991). Oligomeric N of CHPV once formed was only able to loosely associate with
RNA instead of forming true encapsidation complex (Bhattacharya et al. 2006). Finally,
complex formation with P was proposed to suppress non-specific RNA binding ability of
N, therefore, channel N protein towards viral specific sequences within infected cells
(Masters and Banerjee 1988a). Our current model, consistent to this observation,
proposes that N protein maintained in monomer form through its association with P
would exhibit such RNA binding specificity.
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However, disc-like structures obtained by co-expressing VSV N and P protein was
non-specifically bound to RNA (Green et al. 2000, 2006). These results were in apparent
contrast to a proposed function of P to prevent non-specific RNA binding (Masters and
Banerjee 1988a) and also to the observed RNA binding specificity of CHPV N-P
complex (Bhattacharya et al. 2006). VSV expression system allowed N to form 2:1
complex with P and therefore it appears that stoichiometry of N–P complex plays a
critical role in RNA binding specificity. Such suboptimal level of P would result in a
trimeric assembly with two N molecules and one P protein, while, N–N association within
those complexes may allow for non-specific RNA binding. However, N–P complex with
one monomer from each protein provides RNA recognition specificity of N. It is
interesting to note that a 1:1 molar complex between N and P protein was proposed to be
most efficient in supporting viral replication (Peluso 1988; La Ferla and Peluso 1989).
Nonetheless, above studies established a requirement for stoichiometric amount of P,
independent of its role in transcription, to prevent both oligomerisation and aggregation
of N and to ensure supply of soluble encapsidation competent N. However, based on
current proposal, in would be necessary to elucidate monomer N protein structure to
understand its RNA binding specificity in Chandipura virus system. Proposed
conformation alterations due to N–N association also need to be investigated. As N
protein lacks any well-characterized RNA binding motifs; most striking aspect of this
proposal is an intrinsic RNA binding specificity that is hardwired within N molecule. If
true, this may allow for development of small molecule inhibitors of nucleation as
potential antiviral agents. Further mutagenic analysis on N protein to dissect
oligomerisation, P binding and RNA binding will shed light on Chandipura virus
nucleocapsid assembly pathways. Nonetheless, encapsdiation process exemplifies
coordinated operation of multiple viral components to perform single function, viz
genome packaging.
Leader RNA and Trailer Sequence
Leader gene positioned at the extreme 3¢end of the genome is one of the first to be
transcribed and codes for 49 nt-untranslated, uncapped and non-polyadenylated leader
RNA of (+) polarity. VSV leader RNA was recovered from virus-infected cells in a
nucleocapsid-like structure (Blumberg and Kolakofsky 1981) and was postulated to be
an abortive replication product and not synthesized during transcription (Barr et al.
2002, Whelan and Wertz 2002). However, as discussed later, post-synthesis encapsdi-
ation of leader transcript appears to be possible within virus-infected cells. In this
regard, it would be important to investigate temporal profile for synthesis of leader
RNA within CHPV infected cells to ensure it to be an immediate early viral transcript.
Precise physiological function of l-RNA has remained unclear. Although, it was
proposed to localize into the nucleus (Kurilla et al. 1982) and interferes with host DNA-
dependent RNA synthesis (McGowan et al. 1982). VSV leader RNA was shown to
interact with components of hnRNP U in the nucleus which may explain its inhibitory
function on host mRNA synthesis (Gupta et al. 1998). VSV l-RNA was also shown to
binds with La, a protein that modulate RNA polymerase III transcription (Kurilla and
Keene 1983). Studies on Rinderpest virus, a paramyxovirus, not only identified similar
interaction between leader RNA and La protein but also revealed a possible role for La
in the cytoplasm in modulating viral RNA synthesis by its ability to bind nascent l-RNA
(Raha et al. 2004b).
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Most important function of leader sequence, however, is to provide specific
nucleation signal for initiation of N-mediated encapsidation of genomic analogues.
Critical sequence elements on leader chain for N binding was identified to reside at the
genome termini (Pattnaik et al. 1995) and apparently first 21 nucleotide of l-RNA was
sufficient for nucleocapsid assembly (Li and Pattnaik 1999). In vitro studies with CHPV-
N revealed that first half of the leader RNA (1–20) was sufficient for specific
encapsidation complex formation (Bhattacharya et al. 2006). Comparison of the
sequences revealed that only two nucleotides, 8th and 19th residue from 5¢end of the
anti-genome RNA, within the first half of the leader gene differ among VSVind, VSVnj
or CHPV. Whereas second half of the leader gene showed considerable sequence
diversity (Marriott 2005). Consistently, the second half of the l-RNA of CHPV was
shown dispensable for specific encapsidation in vitro (Bhattacharya et al. 2006).
However, recent studies revealed potential for presence of a structural element within
second half of the CHPV leader RNA that may regulate viral replication (Basak et al.
2003). Nonetheless, trailer sequence present at the 5¢end of the viral genome, specially
extreme 20 nt, shows extensive sequence complementarities with leader region thus
strongly supports proposed copy back mechanism in generating DI particles (Nichol and
Holland 1987).
Promoter and Terminator Elements
Efforts by several groups led to identify cis-acting signals embedded within
vesiculovirus genome that modulate transcription or mRNA modifications. In vitro
reconstituted synthetic nucleocapsid analogues indicated that first 15 nt at the 3¢end
of the genome plays an essential role in modulating polymerase entry to the
template (Smallwood and Moyer 1993). However, G. W. Wertz and coworkers
employed reverse genetics to report necessity of two distinct elements at 19–29 and
34–46 from the 3¢end of the genome, that regulate VSV transcription activity from
sub-genomic template (Whelan and Wertz 1999, Walpita and Flick 2005). In a
separate study, Li et al. also proposed a role for sequences from 25 nt to 47 nt in
modulating viral transcription beside first half of the leader gene (Li and Pattnaik
1999).
Presence of core promoter element associated with each transcription unit was
further investigated by mutagenic analysis of bipartite minigenome replicon to identify
3¢-UYG-5¢ tri-nucleotide at the beginning of each five protein coding genes as necessary
element for transcription initiation and capping of the mRNA (Stillman and Whitt
1999). In this regard, vesiculovirus uses promoter elements that are downstream of
initiation site and resembles with downstream promoter elements found within
mammalian transcriptional repertoire (Kadonaga 2002). Leader gene present at the
extreme 3¢end of the genome of CHPV and other vesiculoviruses, however, lacks this
conserved tri-nucleotide and poses 3¢-UGC-5¢ sequence. Strikingly, sequence analysis
among different mononegavirales revealed a more general consensus 3¢-UNC-
NNNUUNN-5¢ at the beginning of transcriptional units (Stillman and Whitt 1997),
which significantly differ in the +3 residue from a conserved VSV sequence proposed by
mutagenesis analysis. Therefore, distinct promoter sequence requirement of vesiculo-
virus RdRp could be envisioned whereby optimal transcription from the protein coding
ORF may require a G in +3 site to synthesize capped RNA.
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Nevertheless, similar mutagenesis study was employed to propose intergenic non-
transcribed dinucleotide 3¢G/CA5¢ as an essential element for efficient transcription
termination (Stillman and Whitt 1997). A conserved tetranucleotide sequence (3¢-
AUAC-5¢) followed by a U7 tract present at the end of each gene was proposed to
ensure proper termination and poly-adenylation of mRNA (Barr et al. 1997). Except for
G/L junction, the gene junctions are highly conserved between CHPV and VSVind
serotype indicating that a general mechanism is employed by vesiculoviruses to regulate
gene-expression. While, for VSVind, G/L junction still has a dinucleotide in the
intergenic space, VSVnj or CHPV contains 20 and 21 nucleotide in between G and L
transcription units, respectively (Marriott 2005). However, direct investigations to
identify cis-acting signals required for CHPV gene-expression has been impeded due to
lack of reverse genetics system. Recently, a minigenome-based replicon of Chandipura
virus was constructed and efforts are currently underway to reveal sequence codes for
transcriptional initiation and termination (A. Majumdar and D. Chattopadhyay 2006,
Unpublished data).
It is worth mentioning that research on eukaryotic transcription has highlighted
critical function of distant enhancer elements, regulations via conformational alterations
of chromatin and finally important role for chromatin modifying enzymes. While,
minigenome based studies are, otherwise, informative does not allow studying viral gene
expression within its proper full-length nucleocapsid context. Therefore, parallel
experimental approaches must be undertaken to investigate possible conserved
mechanisms underlying gene-expression in mammal and mammalian RNA viruses.
Transcription and Viral RNA Dependant RNA Polymerase
Vesiculovirus transcription is characterized by actinomycin D resistant synthesis of
leader RNA and viral mRNAs. Order of transcription of VSV genes was determined by
in vitro transcriptional mapping analysis using UV-radiation. Such studies revealed that
VSV mRNAs are synthesized in an obligatory sequential manner after polymerase
entry at single 3¢end of the genome termini i.e. at the beginning of leader gene (Ball and
White 1976, Abraham and Banerjee 1976; Testa et al. 1980). Determination of relative
molar ratios of different viral mRNAs within infected cells revealed that their
abundance decreased with increasing distance from the 3¢ promoter in an order
N>P>M>G>L, thus implying a mechanism that also ensures polar transcription
(Villarreal et al. 1976, Iverson and Rose 1981). More recently, an engineered version
of VSV was utilized where an additional transcriptional unit (I) was inserted at N–P, P–
M, M–G or G–L gene junction. Quantitation of I mRNA relative to the 3¢ proximal
VSV N mRNA expressed within cells infected with recombinant virus, consistently,
revealed a gradual decrease in I mRNA synthesis with increase in distance from 3¢
termini of the genome (Wertz et al. 2002).
To explain polar and sequential mRNA synthesis, Emerson et al. postulated stop-
start model for transcription (Fig. 3) that remains most widely accepted, till date
(Emerson 1982). In this model, subsequent to single site entry at the beginning of leader
gene, viral polymerase sequentially transcribes the genome with progressive attenuation
at each gene boundary to result in decreasing amount of transcripts for genes that are
distant from the entry site. Each termination event may lead to the polymerase to fall
off from the template or may allow for re-initiation at the downstream promoter.
Therefore, transcription from downstream genes is dependent on termination of
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upstream genes and reinitiation. This proposal explained observed polarity during
transcription, while, anti-termination by polymerase at the gene boundaries results in
synthesis of replication product (Banerjee a, b,). Consistent to single site entry model,
VSV polymerase was able to predominantly produce ppAC dinucleotide representing 5¢
dinucleotide of the leader RNA in an incomplete in vitro transcription reaction that was
supplemented with only ATP and CTP and not ppAACA tetranucleotide that
represents beginning of a mRNA, (Emerson 1982).
An alternative model for multiple entry site was also proposed that describes
multiple independent initiations at each gene promoter. Experimental support for this
model was gathered when an internal polymerase entry site was described to explain
VSV-DI particle synthesis (Schubert et al. 1979). Furthermore, a mutant version of
polymerase was shown to be able to mediate internal entry at the beginning of N gene
in vitro (Chuang and Perrault 1997). While, this model lacks supports of experiments
done on wild type virus, it was also unable to explain experimentally observed polar
transcription in vesiculoviruses. However, a modified version of this model has recently
been proposed to suggest two separate RNA synthesis initiation sites, at the beginning
of N gene or leader gene, during transcription or replication, respectively (Whelan and
Wertz 2002; Barr et al. 2002). Merit of such proposal will be further discussed in later
section in light of Chandipura virus research.
Large Protein L
Viral transcriptase is composed of L and P protein. L retains the catalytic activity of
RNA polymerization, capping and polyadenylation. Vesiculovirus L protein shares a
conserved structural module similar to that of a right hand, with palm, thumb and
fingers domain, whereas, the palm domain structure is particularly conserved in almost
all RNA-dependent RNA polymerases (Ahlquist 2002). Not surprisingly, comparison of
Transcription Replication
Leader Int. N
Region
Leader Int. N
Region
• Termination
• Re-initiation
• Anti-termination
• Encapsidation 
Leader RNA and five capped
mRNAs
Full-length anti-genome
P0
P1
N
L
RNA
Capped RNA
Fig. 3 RNA synthesis events of Chandipura Virus. Viral polymerase composed of L and phosphorylated
form of P protein transcribes the genome RNA with progressive attenuation at each intergenic region
(Int Region) to synthesize leader RNA and five capped and poly adenylated mRNA. RdRp was
proposed to remain associated with N-RNA while transcribing the genomic template and reinitiate
synthesis of downstream genes after termination. However, during replication mode, the same
polymerase read-through the termination signals present at the intergenic region to eventually copy
the entire genome. N protein is recruited on nascent genome RNA to protect it form cellular RNase
action as it is synthesized. Unphosphorylated form of Phosphoprotein recruited to leader RNA has been
proposed to modulate polymerase activity during replication to bring about anti-termination
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deduced amino acid sequence of L protein of CHPV with that of different
rhabdoviruses exhibited a high degree of homology along the length of the protein.
Four conserved motifs present in VSV (Poch et al. 1989) are also present within CHPV-
L in a central block that is thought to mediate RNA polymerization (Marriott 2005).
A unique feature of VSV mRNA synthesis is involvement of L protein in 5’end
modification of the nascent mRNA that includes methylation and capping. However,
unlike cellular guanylyltransferase, L protein incorporates GDP rather than GMP in the
capped structure as Gp(alpha)p(beta)-p(alpha)A. The 5¢end modification events were
proposed to be successive to transcription initiation, whereby, nascent mRNA termini
maintains contact with transcribing polymerase until modified (Stillman and Whitt
1999). Notably, leader RNA lacks 5¢ cap structure. This may have resulted from the lack
of a consensus trinucleotide sequence at the 5¢end of leader RNA that is otherwise
present in the other mRNA species; or may reflect requirement for a minimum
transcript length for capping. Addition of poly(A) tail to the viral mRNA is also
attributed to the L protein, where, polymerase slippage during transcription termination
at U7 tract is believed to add A residues at the 3¢end of mRNA (Barr et al. 1997). A
protein kinase activity was also found to be associated with the purified VSV-L that has
been termed as L associated kinase, LAK. It is still not clear, if the protein kinase
activity is intrinsic to the L polypeptide or reflects a co-purified cellular kinase (Banerjee
1987a, b). Nevertheless, L protein remains associated with translation elongation factor,
EF1; while, EF1–bc complex was proposed to constitute LAK activity, EF1–a may
participate in the capping by virtue of GTP/GDP binding activity (Das et al. 1998).
Therefore, it seems likely that L protein in conjunction with Phosphoprotein P and
other cellular components, synthesize viral mRNA within infected cells and offers for
mechanisms that could be potential drug targets, such as its unique capping or RNA
dependent RNA polymerase activity. Nevertheless, a recombinant expression system to
study structure and function of CHPV-L is yet not available and is required for
additional analyses.
Phosphoprotein P in Transcriptional Regulation
Successful in vitro reconstitution of Chandipura virus transcription with purified
components by Chattopadhyay et al. (1997) was an important step towards developing
mechanistic insight into transcription. To this end, RNP particle obtained from
detergent disrupted virus was treated with high salt buffer to dissociate N-RNA from L
and P. Subsequently, N-RNA collected on the glycerol cushion or released L and P
protein collected from the top of the gradient was further purified following rigorous
biochemical protocol. When, purified L protein was incubated with N-RNA in a
reaction mixture that allows for in vitro transcription, it was unable to synthesize viral
mRNA. However, addition of viral P protein along with L, and not P alone, allowed for
viral mRNA synthesis. These studies confirmed a role of Phosphoprotein as an activator
of viral transcription (Chattopadhyay et al. 1997) and this proposed function was
consistent to the observations made in VSV (Banerjee 1987b).
Chattopadhyay and Chattopadhyay (1994) cloned Phosphoprotein gene of CHPV to
express in bacteria and used purified recombinant protein to understand importance of
post-translational modifications of P. P, a 32.5 kDa protein when analyzed on SDS-
PAGE shows anomalous migration with apparent molecular weight of 50 kDa. Studies
with recombinant P protein critically showed that negatively charged N-terminal
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domain was responsible for such anomalous migration. However, when viral P was
substituted with its bacterially expressed counterpart, it failed to support transcription
from N-RNA template, implying requirement for additional modifications for P protein
function (Chattopadhyay et al. 1997). P of both VSVind and VSVnj serotypes was
extensively phosphorylated within infected cells at multiple sites (Hsu and Kingsbury
1982; Banerjee 1987a; Clinton et al. 1979). Accordingly, a role for host derived kinases
was proposed in modifying P at specific residues (Barik and Banerjee 1992a; Clinton
et al. 1982). Casein Kinase II (CKII) was shown to be responsible for phosphorylating P
of both VSV serotypes (Banerjee 1987b; Barik and Banerjee 1992a). Studies with
recombinant CHPV-P revealed CKII, indeed similarly phosphorylates P in vitro
(Chattopadhyay and Chattopadhyay 1994), although, CHPV-P exhibited less than
20% homology with P protein from other vesiculoviruses (Masters and Banerjee 1987).
Further investigations identified serine-62 at the N-terminal acidic domain of CHPV P
protein was specifically modified by CKII (Chattopadhyay et al. 1997). Only CKII
phosphorylated form of recombinant P could effectively substitute P protein purified
from virus to support transcription from nucleocapsid template in vitro (Chattopadhyay
et al. 1997). A mutated version of P protein with alanine substituted for serine62, when
tested in vivo was unable to activate transcription and rather inhibited viral mRNA
synthesis in a trans-dominant manner (Basak et al. 2003). Therefore, CKII mediated
phosphorylation appeared to be indispensable for P to act as a transcriptional activator.
The C-terminal domain of P was proposed to associate with N-RNA template during
transcription, thus tethers polymerase with its template and provide processivity during
transcription (Gao and Lenard 1995).
VSV-P protein existed within virus infected cells in two distinct phosphorylated
states, namely P1 and P2, while unphosphorylated form of P was designated as P0. It
was proposed that CKII mediated phosphorylation at the N-terminal region of P0
generates P1 form, which undergoes further round of modification by L-associated
kinase at its C-terminal domain to form P2. This sequential phosphorylation event was
proposed to modulate transcriptional activation property of VSV-P (Barik and Banerjee
1992a, b; Banerjee 1987b; Chattopadhyay and Banerjee 1987). Mutational analysis
identified serine62 in CHPV-P as single phophorylation site in vivo to suggest existence
of only P0 and P1 forms (Basak et al. 2003). However, a high turn over rate of
phosphates incorporated by LAK could potentially result in a failure to identify such C-
terminal phosphorylations of P in vivo. Nevertheless, detergent disrupted Chandipura
virus incubated in an in vitro transcription reaction produced leader RNA and viral
mRNAs, thus, confirming packaging of an active form of polymerase within mature
virion (Basak et al. 2003).
Interestingly, studies on transcription complexes of respiratory syncitial virus, a
paramyxovirus, indicated that P protein phosphorylation by CKII is required for
promoter clearance and transcription elongation (Dupuy et al. 1999). These observa-
tion, therefore, suggest a post-initiation function for P-protein phosphorylation in
transcription and in parallel with the proposed role for C-terminal domain phosphor-
ylation of eukaryotic RNA polymerase II. Analysis in Chandipura virus, although, is
consistent to a role for P1 in transcription initiation, additional function of P protein
phosphorylation in elongation remains to be tested.
How does phosphorylation of P protein regulate its function as transcription
activator? Phosphorylated P forms dimer (Chattopadhyay et al. 1997) and N-terminal
46 amino acids were proposed to be responsible for phosphorylation-mediated
dimerisation (Raha et al. 2000). Accordingly, a critical role for phosphorylation
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mediated dimerisation was proposed that regulate P protein function in transcription via
efficient polymerase interaction (Gao and Lenard 1995). However, large zone gel-
filtration technique was employed to reveal gradual appearance of dimer and tetramer
species within unphosphorylated P protein pool in a concentration dependent manner.
This observation was further substantiated by measuring sedimentation coefficient of
those different oligomer species using analytical ultracentrifugation technique and
measuring hydrated diameter by dynamic light scattering (Basak et al. 2004). Further-
more, Ding et al. (2006) has recently reported crystal structure for dimerisation domain
of VSVind P protein, first of its kind for any vesiculovirus P. Intriguingly, such analysis
indicated that a central domain, spanning 107–177 residues, mediate dimer assembly of
the P protein in its unphosphorylated form. This central domain is composed of a a-helix
surrounded by two b-hairpins. While, a-helix forms dimer, two b-hairpins from each P
protein engages into domain swapping to form four stranded b-sheet and provides
stabilizing force. In light of Chandipura research, it seems possible that N-terminal
domain of P may provide additional stabilizing interactions by exposing coiled-coil motif
upon phosphorylation (Raha et al. 1999, 2000), although, such domain is probably not
required for dimerisation per se. Whereas, central domain assembles P into a dimer even
in its unphosphorylated form. Therefore, dimerisation alone was not sufficient to explain
transcription activation property of phosphorylated P.
Biophysical studies with CHPV-P protein revealed that phosphorylation at serine62
induced a major structural change within N-terminal domain of P protein to expose
cystein57 on the protein surface (Raha et al. 1999). Phosphorylation also resulted in
tryptophan residues to burry inside protein core, while, maintaining overall flexibility of
the N-terminus. Accordingly, such conformation changes within the N-terminal domain
of P were proposed to facilitate precise polymerase contact by P1 to result in optimal
transcription (Raha et al. 1999). Lack of such N-terminal phosphorylation in P may also
induce an altered conformation in interacting L protein, thus forming replicase complex,
as discussed later (Basak et al. 2003; Gupta et al. 2003).
Replication and its Regulation
Chandipura virus replicative cycle is characterized by read-through of the gene
boundaries by viral polymerase to synthesize an exact complement of (–) sense genome
RNA. The molecular mechanism that allowed for a switch in polymerase function from
transcription to replication, in other words, to ignore termination signals at the gene
boundaries, has remained obscure. Studies in recent years on both CHPV and VSV led
to a different proposal to explain vesiculovirus transcription-replication switch.
Two Separate Promoters for Transcription and Replication
According to this proposal, initiation of viral transcription predominantly occurs at the
beginning of N gene, while, polymerase initiates replication at the beginning of leader
gene. Both the processes utilize same nucleocapsid template, whereas, modifications of
the viral polymerase allow for binding at separate sites during replication (Whelan and
Wertz 2002; Barr et al. 2002). Indeed, a complex from VSV-infected cells composed of
L, P and N protein was isolated that showed replication activity, in vitro (Gupta et al.
2003). Phophorylation of P was shown to be dispensable for the activity of this proposed
tripartite replicase complex, thus, separating it from the classical L-P1 transcriptase
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complex. Accordingly, it was postulated that the integration of de novo synthesized N
protein into a replicase complex resulted in differential promoter recognition by
polymerase to initiate replication phase.
Although, such model could not satisfactorily explain generation of leader RNA
during viral RNA synthesis (Blumberg and Kolakofsky 1981). In this proposal, abortive
replication attempts by polymerase resulted in accumulation of leader RNA within
cells. However, in vitro transcription with Chandipura virus nucleocapsid resulted in
synthesis of leader RNA (Basak et al. 2003). Even as replication byproduct, presence of
discrete leader RNA species within virus-infected cells implies a strong attenuation
signal for polymerase at the leader-N boundary, that needs to be suppressed for
productive replication. Also this model was proposed based on studies on an engineered
version of VSV that can substantially differ from wild type virus in nucleocapsid
conformation, thus, may allow for observed internal entry of the polymerase.
Involvement of N protein and an auxiliary function for P
Viral replication was shown to critically depend on de novo synthesis of N protein
(Patton et al. 1984) and accordingly a role for N in genome replication was proposed. N
mediated encapsidation of nascent leader RNA suppress termination signal at the
leader-N gene boundaries to eventually bring about the replicative phase (Blumberg
et al. 1981). Accordingly, selective nucleation signal for N binding was identified within
first 20 nt of (+) leader RNA for both VSV and CHPV system, as discussed. However,
accumulation of critical amount of replication competent N is controlled by P protein
(Bhattacharya et al. 2006). Essentially, P maintains N in a monomer form that engages
in specific nucleation on the leader chain to form nucleocapsid.
How ensuing encapsidation of nascent RNA would influence termination or anti-
termination decision of transcribing polymerase has remained debatable. One possible
explanation was provided in studies with Influenza virus, where a direct interaction
between RNA bound N proteins and polymerase was proposed (Biswas et al. 1998). In
VSV, encapsidation was proposed to oppose polymerase pausing at the gene-
boundaries to bring about anti-termination. However, clear biochemical evidence for
such proposal is still missing (Banerjee 1987a). Chandipura virus, when allowed to
multiply within cells with a preformed pool of N–P1 complex, showed negligible
enhancement in replication, implying existence for additional mechanism in catalyzing
transcription-replication switch (unpublished observation). Also, a stoichiometric
amount of N is required to encapsidate viral RNA to protect it from RNase action
and stabilize the single stranded genome within nucleocapsid core. Therefore, it could
be questioned if N is actually required for the onset of genome replication (catalyzing
replication) or its role is confined in protecting replication product from degradation
(stoichiometric role). It seems possible that a major role for N in providing protection
to progeny genome RNA may have resulted in an over-estimation of its function in the
onset of replication.
Role for Unphosphorylated P protein
Recently, research in both CHPV and VSV indicated a rather surprising function for P
in its unphosphorylated form in viral replication. A minigenome-based assay using VSV
DI-RNA revealed that N-terminal phosphorylations of P protein, although, necessary
for transcription, were dispensable for viral replication in vivo (Pattnaik et al. 1997). On
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the other hand, C-terminal basic residues of VSV P protein was shown to be required
for transcription and not for replication (Das et al. 1997). A tripartite complex
composed of transcriptionally inactive mutant of P, and wild type L and N protein
efficiently synthesized 42 S replication product in vitro (Gupta et al. 2003). These
studies predicted possible engagement of distinct biochemical forms of P in viral
transcription or replication processes. Chandipura virus, when allowed to multiply in
presence of a pre-existing pool of phosphorylation defective mutant of P, revealed a
two-log increase in the viral yield as compared to that of phosphorylated P protein.
Presence of such phosphorylation defective P within the cellular milieu, resulted in an
temporal alteration with early onset for genome replication and also mediated
quantitative effect with an increase in viral genome synthesis (Basak et al. 2003).
These studies were not only consistent to the similar observations in VSV but also
conducted in a manner that allowed understanding the role of P protein phosphory-
lation in transcription and replication in the context of wild type virus. Moreover,
detergent disrupted Chandipura virus, when incubated with a phosphorylation defective
mutant of P in an in vitro transcription reaction, synthesized products that corresponds
to read-through RNA of leader-N junction. These experiments critically showed that
unphosphorylated form of P alone could catalyze anti-termination of leader-N junction
in vitro.
However, Basak et al. subsequently presented another intriguing observation that
connected a role for P0 in viral replication with events on nascent leader RNA chain. In
their study, CHPV-P protein was shown to specifically bind with leader RNA in its
unphosphorylated form, whereas, CKII mediated phosphorylation abrogated its RNA
binding ability (Basak et al. 2004; Basak 2003). Leader RNA-P0 interaction was distinct
from N-mediated encapsidation of viral RNA. Moreover, oligomeric status of P0 was
shown to partly alter its RNA binding pocket thus fine-tunes P0 assembly on leader
chain (Basak et al. 2004). Accordingly, a new model was proposed to explain
Chandipura virus genome replication (Basak et al. 2003). In this proposal, recruitment
to nascent leader chain allows P0 to interact with transcribing polymerase in the vicinity
and alters polymerase conformation in a manner that enables read-through at the gene-
boundaries (Fig. 3). Consistently, structural differences between activation domains of
P0 and P1 was reported in CHPV (Raha et al. 1999). Theoretical analysis of prokaryotic
transcription also revealed that a transcriptional activator may acts as a repressor by
mediating differential contact with polymerase (Roy et al. 1998). Therefore, this model
predicts that such differential contact may enable anti-termination by mammalian virus
RNA polymerase during transcription. Nonetheless, progressive encapsidation of
nascent RNA by N maintains processivity of replicase complex to allow for synthesis
of ~11.1 kb (+)ve sense genome. Progeny (+)ve sense genome, however, lacks
transcription termination elements, thus, exclusively acts as template for replication
to synthesize more copies of (–)ve sense genome RNA. M2–1 phosphoprotein of human
respiratory syncytial virus, a paramyxovirus, was shown to bind leader RNA whereby
binding affinity was reduced upon phosphorylation (Cuesta et al. 2000). Similar
phosphoregulation of RNA binding of P protein was also reported for Rinderpest
virus, another paramyxovirus, to postulate a conserved function of leader RNA-P0
interaction in mononegavirus life-cycle (Raha et al. 2004a). Notably, the proposed
mechanism for Chandipura virus to read-through its gene-boundaries during replication
bears remarkable similarity to the N mediated anti-termination strategy employed by
bacteriophage k (Rees et al. 1996; Oppenheim et al. 2005). It also constitutes an
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example of protein economy, whereby; a single protein in two different forms has been
used in two distinct steps of viral RNA synthesis.
Chandipura virus P protein posses a consensus CKII site enclosing serine-62 (-Ser-
Glu-Glu-Asp-), as discussed earlier. CKII, being a ubiquitous kinase raises a question of
possible existence of unphosphorylated P protein within virus infected cells. However,
Basak et al. has recently postulated a phosphatase activity that is induced upon
Chandipura virus infection within BHK-21 cells and capable of dephosphorylating P
protein (Basak 2003). Induction of this phosphatase activity remarkably coincides with
the onset of genome replication. Curiously, recent studies identified a conserved
Glu64Asp mutation within P protein in all epidemic isolates (Arankalle et al. 2005). In
light of proposed function of unphosphorylated P protein in boosting up viral
replication, functional consequences of such mutations in viral life-cycle need to be
tested.
Concluding Remarks
In this review, we have attempted to provide details of Chandipura virus life cycle.
Clearly, our understanding of the virus partly relies on contemporary studies on VSV,
and remarkable similarities between CHPV and VSV provide basis for some of the
generalized conclusions. While, proposed mechanism for CHPV replication that
involves RNA binding by Phosphoprotein needs to be tested in VSV, existence of
distinct mechanisms in different serotypes of vesiculoviruses could not be completely
ruled out. Reverse genetic tools need to be employed along with biochemical
experiments for further characterizing CHPV pathogenesis at molecular details. While
retaining general academic interest for mechanism of RNA synthesis in rhabdoviruses,
future Chandipura research should also focus on development of potential anti-viral
therapeutic interventions that allows for specific inhibition of viral growth without any
pleotropic effect on cellular metabolism. Available reagents and a large body of
information on N-P, N-leader RNA or P0-leader RNA interactions should be utilized to
screen chemical library to identify compounds that inhibits such interactions in vitro
thus detrimental to viral multiplication in vivo.
Interestingly, we noticed that almost each protein of Chandipura virus executes
multiple different tasks within viral life cycle, therefore, constitutes for an example of
protein complexity and economy. Catalytic activity for RNA dependent RNA
polymerization, 5¢ end capping of mRNA and poly-adenylation activity is contained
within L gene. Matrix protein M, beside its role in viral assembly, is also used for
interfering with host cellular metabolism. Nucleocapsid protein N has multiple targets
whereby it interacts with both P protein and viral RNA to form precise nucleocapsid
template. Phosphoprotein P in its distinct phosphorylated state can act as either
transcriptional activator or an anti-terminator. We propose that fragility of single
stranded RNA molecule and replicative advantage of compact genome due to shorter
replication cycle imparts constrain on Chandipura virus genome length. Accordingly,
Chandipura virus has evolved an economic way to use single viral protein in multiple
different related functions rather encoding separate genes with specialized missions.
This proposed mode for evolution of proteins encoded within RNA genome
predicts utilization of distinct structural motifs and novel functional mechanisms by
rhabdoviruses.
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